27.01.2022 | Brief Communication
Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson’s disease
verfasst von:
Weifang Yin, Yongyun Zhu, Baiyuan Yang, Fang Wang, Kangfu Yin, Chuanbin Zhou, Hui Ren, Xinglong Yang
Erschienen in:
Neurological Sciences
|
Ausgabe 4/2022
Einloggen, um Zugang zu erhalten
Abstract
The present study aimed to explore the association of plasma neurofilament light chain (NfL) levels with depression and anxiety in Parkinson’s disease (PD). This prospective study enrolled 116 patients with PD and 38 healthy controls, and found plasma NfL levels were higher in patients with depression or anxiety than in those without these symptoms. Binary logistic regression identified NfL concentration as an independent predictor of depression and anxiety in PD. In conclusion, elevated plasma NfL may be associated with severity of depression and anxiety in PD patients and may serve as a diagnostic biomarker of PD with moderate to severe depression or anxiety.